Regeneron develops new medicines and it rang up $3.7 billion in sales for its anti-inflammatory drug Dupixent as a treatment for eczema, asthma and chronic obstructive pulmonary disease, in its latest ...

Memorial Day sales are here! Shop our favorites from summer fashion to barbecue essentials. Score deals from Old Navy, Shark, ...

Several ASX companies are focused on the growing potential of microbiome-based diagnostics, therapeutics, and wellness ...

Discover a study that where results demonstrated significantly greater improvement in the ivarmacitinib groups compared to ...